Filter-based cerebral embolic protection with transcatheter aortic valve implantation: the randomised MISTRAL-C trial

EuroIntervention 2016;12:499-507. DOI: 10.4244/EIJV12I4A84

Nicolas  M. Van Mieghem
Nicolas M. Van Mieghem1*, MD, PhD; Lennart van Gils1, MD; Habib Ahmad2, MD; Floortje van Kesteren3, MD; Hendrik W. van der Werf4, MD; Guus Brueren5, MD, PhD; Michiel Storm6, MSc; Mattie Lenzen1, PhD; Joost Daemen1, MD, PhD; Ad F.M. van den Heuvel4, MD, PhD; Pim Tonino5, MD, PhD; Jan Baan3, MD, PhD; Peter J. Koudstaal6, MD, PhD; Marguerite E.I. Schipper7, MD, PhD; Aad van der Lugt2, MD, PhD; Peter P.T. de Jaegere1, MD, PhD
1. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands; 4. Departmen

Aims: Our aim was to determine whether use of the filter-based Sentinel™ Cerebral Protection System (CPS) during transcatheter aortic valve implantation (TAVI) can affect the early incide

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic stenosiscerebral embolic protectiontranscatheter aortic valve implantation (tavi)
Interventions for valvular diseaseTAVITools, devices and techniques
Read next article
Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function

Latest news